Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-051313)

Filing Details

Accession Number:: 0001209191-22-051313
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-09-27 08:01:27
Reporting Period:: 2022-09-26

Accepted Time:: 2022-09-27 08:01:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1828522	Effector Therapeutics Inc.	EFTR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1293973	B Christopher Ehrlich	C/O Effector Therapeutics, Inc. 142 North Cedros Avenue, Suite B Solana Beach CA 92075		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-09-26	18,867	$0.55	34,867	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	142,168	Indirect	By Locust Walk Partners LLC
Common Stock	1,034	Indirect	By Locust Walk Partners LLC

Footnotes

Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person.
Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse.